Amit Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.93 M
as on 11-12-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 11-12-2024
- Satisfied Charges ₹ 2.00 Cr
as on 11-12-2024
- Revenue 173.15%
(FY 2020)
- Profit 830.31%
(FY 2020)
- Ebitda 495.06%
(FY 2020)
- Net Worth 34.93%
(FY 2020)
- Total Assets 27.62%
(FY 2020)
About Amit Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.93 M.
The company currently has active open charges totaling ₹1.00 M. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Racchana Rastogi and Amit Rastogi serve as directors at the Company.
- CIN/LLPIN
U51909WB2006PTC110950
- Company No.
110950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Amit Biotech Private Limited offer?
Amit Biotech Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Insecticides, Swimming Pool & Water Sport Goods, Swimming Pool Chemicals, Biofungicides, Bird Food, Poultry & Animal Food, Fish Foods, Fertilizers and Soil Additives, Plant Growth Promoters, Chemical Reagents & Catalysts.
Who are the key members and board of directors at Amit Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Rastogi  | Director | 29-Jul-2006 | Current |
| Racchana Rastogi | Director | 29-Jul-2006 | Current |
Financial Performance of Amit Biotech.
Amit Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 173.15% increase. The company also saw a substantial improvement in profitability, with a 830.31% increase in profit. The company's net worth Soared by an impressive increase of 34.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amit Biotech?
In 2019, Amit Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 Apr 2019 | ₹1.00 M | Open |
Others Creation Date: 23 Aug 2016 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Amit Biotech?
Unlock and access historical data on people associated with Amit Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amit Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amit Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
